Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression
Seung-Hoon LEE; Cheolmin SHIN; Young-Hoon KO; Moon-Soo LEE; Moon-Ho PARK; Chi-Un PAE; Ho-Kyoung YOON; Changsu HAN.
Clinical Psychopharmacology and Neuroscience
; : 147-161, 2023.
Artículo en Inglés | WPRIM | ID: wpr-966687
Documentos relacionados
Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression.
Effect of Fibrate Treatment on Circulating Adipokine Levels: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Yoga training modulates adipokines in adults with high-normal blood pressure and metabolic syndrome.
Serum plasminogen activator inhibitor-1 levels in patients with major depressive disorder vs. healthy controls: a systematic review and meta-analysis.
Concentration of Selected Adipokines and Factors Regulating Carbohydrate Metabolism in Patients with Head and Neck Cancer in Respect to Their Body Mass Index.
Increased thromboinflammatory load in hereditary angioedema.
Effects of a high-fat meal on inflammatory and endothelial injury biomarkers in accordance with adiposity status: a cross-sectional study.
Association of dietary patterns with serum adipokines among Japanese: a cross-sectional study.
Redistribution of TPA Fluxes in the Presence of PAI-1 Regulates Spatial Thrombolysis.
Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer.